IP Library Granted Patent US 7,579,471
Granted Patent B2
US 7,579,471 · App. 11/696,642 · Granted Aug 25, 2009

Tropane derivatives useful in therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,579,471
App. No.
11/696,642
Granted
Aug 25, 2009
Kind
B2
Abstract

The present invention provides compounds of formula (I) wherein X, Y, R 1 , R 2 and R 3 are as defined hereinabove. The compounds of the present invention are modulators, especially antagonists, of the activity of chemokine CCR5 receptors. Modulators of the CCR5 receptor may be useful in the treatment of various inflammatory diseases and conditions, and in the treatment of infection by HIV and genetically related retroviruses.

Claims (21)

1. A compound of formula (VII), (IX), (XI) or (XIX):

wherein X and Y are selected from CH 2 and NR 4 such that one of X and Y is CH 2 and the other is NR 4 ;

R 3 C 1-4 alkyl substituted by 0 to 3 fluorine atoms;

R 4 is independently R 5 ; COR 5 ; CO 2 R 5 ; CONR 6 R 7 ; SO 2 R 5 ; or (C 1-6 alkylene)phenyl, wherein phenyl is substituted by 0 to 3 atoms or groups selected from C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 alkoxy, C 1-6 alkoxycarbonyl, halogen, CF 3 , OH, CN, NR 6 R 7 , COR 7 , CO 2 R 7 or CONR 6 R 7

R 5 is C 1-6 alkyl; C 2-6 alkenyl; C 2-6 alkynyl; C 3-7 cycloalkyl; a 5 or 6-membered aromatic heterocycle; or a 4 to 7-membered saturated heterocycle; wherein said alkyl, alkenyl, alkynyl and cycloalkyl are substituted by 0 to 3 atoms or groups selected from oxo, halogen, CF 3 , OR 7 , CN, NR 6 R 7 , COR 7 , CO 2 R 7 or CONR 6 R 7 ; wherein said heterocycles contain one to three heteroatoms selected from N, O or S; and wherein said heterocycles are substituted by 0 to 3 atoms or groups selected from C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 alkoxy, C 1-6 alkoxycarbonyl, halogen, CF 3 , OH, CN, NR 6 R 7 , COR 7 , CO 2 R 7 or CONR 6 R 7 ;

R 6 is H; C 1-6 alkyl; C 2-6 alkenyl; C 2-6 alkynyl; C 3-7 cycloalkyl; a 5 or 6-membered aromatic heterocycle; or a 4 to 7-membered saturated heterocycle; wherein said alkyl alkenyl, alkynyl and cycloalkyl are substituted by 0 to 3 atoms or groups selected from oxo, halogen, CF 3 , OR 7 , CN, COR 7 or CO 2 R 7 ; wherein said heterocycles contain one to three heteroatoms selected from N, O or S; and wherein said heterocycles are substituted by 0 to 3 atoms or groups selected from C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 alkoxy, C 1-6 alkoxycarbonyl, halogen, CF 3 , OH, CN, COR 7 or CO 2 R 7 ;

R 7 is H or C 1-6 alkyl;

or when R 6 and R 7 are both attached to the same N atom, NR 6 R 7 may also represent a 5 to 7 membered, saturated, partially unsaturated or aromatic, heterocyde containing from 0 to 2 additional heteroatoms selected from O, N or S;

and Pg is an amino protecting group.

2. A compound of formula (II), (IV), (V), (VI), (XVII), (XXII), (XXIV), (XXV) or (XXVI):

wherein

X and Y are selected from CH 2 and NR 4 such that one of X and Y is CH 2 and the other is NR 4 ;

R 1 and R 4 are independently R 5 ; COR 5 ; CO 2 R 5 ; CONR 6 R 7; SO 2 R 5 ; or (C 1-6 alkylene)phenyl, wherein phenyl is substituted by 0 to 3 atoms or groups selected from C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 alkoxy, C 1-6 alkoxycarbonyl, halogen, CF 3 , OH, CN, NR 6 R 7 , COR 7 , CO 2 R 7 or CONR 6 R 7 ;

R 2 is phenyl substituted by 0 to 3 atoms or groups selected from C 1-6 alkylcarbonyl, C 1-6 alkoxy, C 1-6 alkoxycarbonyl, halogen, CF 3 , OH, CN, NR 5 R 7 , CO 2 R 7 or CONR 6 R 7 ;

R 3 is C 1-4 alkyl substituted by 0 to 3 fluorine atoms,

R 3 is C 1-4 alkyl substituted by 0 to 3 fluorine atoms;

R 5 is C 1-6 alkyl; C 2-6 alkenyl; C 2-6 alkynyl; C 3-7 cycloalkyl; a 5 or 6-membered aromatic heterocycie; or a 4 to 7-membered saturated heterocycle; wherein said alkyl, alkenyl, alkynyl and cycloalkyl are substituted by 0 to 3 atoms or groups selected from oxo, halogen, CF 3 , OR 7 , CN, NR 6 R 7 , COR 7 , CO 2 R 7 or CONR 6 R 7 ; wherein said heterocycles contain one to three heteroatoms selected from N, O or S; and wherein said heterocycles are substituted by 0 to 3 atoms or groups selected from C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 alkoxy, C 1-6 alkoxycarbonyl, halogen, CF 3 , OH, CN, NR 6 R 7 , COR 7 , CO 2 R 7 or CONR 6 R 7 ;

R 6 is H; C 1-6 alkyl; C 2-6 alkenyl; C 2-6 alkynyl; C 3-7 cycloalkyl; a 5 or 6-membered aromatic heterocycle; or a 4 to 7-membered saturated heterocycle; Therein said alkyl, alkenyl, alkynyl and cycloalkyl are substituted by 0 to 3 atoms or groups selected from oxo, halogen, CF 3 , OR 7 , CN, COR 7 or CO 2 R 7 ; wherein said heterocycles contain one to three heteroatoms selected from N, O or S; and wherein said heterocycles are substituted by 0 to 3 atoms or groups selected from C 1-6 alkyl C 1-6 alkylcarbonyl, C 1-6 alkoxy, C 1-6 alkoxycarbonyl, halogen, CF 3 , OH, CN, COR 7 or CO 2 R 7 ;

R 7 is H or C 1-6 alkyl

or, when R 6 and R 7 are both attached to the same N atom, NR 6 R 7 may also represent a 5 to 7 membered, saturated, partially unsaturated or aromatic, heterocycle containing from 0 to 2 additional heteroatoms selected from O, N or S,

and Pg is an amino protecting group.

Assignments (1)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 20, 2023
From: PFIZER INC.
To: PFIZER INC.
Reel/Frame 063119/0087 →